The Policy Behind Democratizing Clinical Trials | Abe Sutton
Guest
Abe Sutton
Deputy Administrator & Director, CMS Innovation Center
A podcast by Selin Kurnaz, Ph.D. | Presented by Massive Bio
This podcast is on a mission to disrupt the old way of cancer care — one conversation at a time.
Spotify
Coming SoonApple Podcasts
Coming SoonAmazon Music
Coming SoonListen to the Show
Episodes
Watch the episodes of the Massively Insightful Podcast.
Coming Soon
Coming SoonComing Soon
Coming SoonEvery Patient Deserves a Fighting Chance.
About the Show
3 – 5%clinical trial enrollment rate
Cancer care has followed the same broken path for too long: too many patients never hear about clinical trials, not because trials do not exist, but because the system was not built to find them. Massively Insightful brings together oncologists, AI researchers, patient advocates, and healthcare innovators to challenge the old model and explore how advanced cancer options can become accessible to every patient, everywhere.
Meet the Host
Selin Kurnaz, Ph.D.
Conversations led by Massive Bio's Co-Founder and CEO.
Selin Kurnaz, Ph.D.
Co-Founder and CEO, Massive Bio
Selin Kurnaz has spent her career asking one question: why do so few cancer patients ever reach a clinical trial? As Co-Founder and CEO of Massive Bio, she built an AI-powered platform that has matched patients to trials across 17 countries and over 190,000 cases. On Massively Insightful, she sits down with the scientists, clinicians, and innovators who are rebuilding oncology from the ground up.
LinkedInSummit Playlist
It Started Live in Dallas.
Before the first episode dropped, the conversation began on stage. The Massively Insightful Summit brought together oncology leaders, AI innovators, and patient advocates around one goal: making clinical trials accessible to every cancer patient who needs one.
Watch the PlaylistNever Miss an Episode.
Massively Insightful will share new conversations on AI, oncology, and the future of clinical trial access. Subscribe options will be available soon.